EFFICACY AND SAFETY OF PASTEURIZED INTRAMUSCULAR ANTI-HBS IMMUNOGLOBULINS FOR HBV RECURRENCE PROPHYLAXIS AFTER LIVER TRANSPLANTATION

被引:0
|
作者
Carrai, Paola [1 ]
De Simone, Paolo [1 ]
Franchello, Alessandro [2 ]
Salizzoni, Mauro [2 ]
Filipponi, Franco [1 ]
机构
[1] Univ Pisana, UO Chirurg Gen & Trapianti Fegato, Azienda Osped, Pisa, Italy
[2] Azienda Osped S Giovanni Battista, Ctr Trapianti Fegato, Turin, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S183 / S184
页数:2
相关论文
共 50 条
  • [21] Anti-HBs antibodies produced after liver transplantation: From the donor or the recipient? Reply
    Lo, CM
    HEPATOLOGY, 2003, 38 (01) : 272 - 272
  • [22] The decay of anti-HBs titer in liver transplant recipients switched from human hepatitis B immunoglobulins to lamivudine prophylaxis
    Angelico, M
    Di Paulo, D
    Trinito, G
    Garbuglia, A
    Mensi, S
    Iaria, G
    Tisone, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 31 - 31
  • [23] Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation
    Ku, Winston
    Wang, Uerica
    Nguyen, Mindie H.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) : 665 - 677
  • [24] Long-term persistence of hepatitis B virus (HBV) in liver transplanted patients under anti-HBS immunoglobulins (HBIG).
    Virot, V
    Samuel, D
    Feray, C
    Gigou, M
    Roche, B
    Arulnaden, JL
    Bismuth, H
    HEPATOLOGY, 1996, 24 (04) : 1167 - 1167
  • [25] ANTI-HBS ANTIBODIES PERSISTENCE AFTER ANTI HBV VACCINATION - MEDIUM TERM RESULTS
    BONI, F
    VIGNOLI, R
    VECCHIA, L
    FILIPPI, G
    TRAMALONI, C
    ATTOLINI, M
    MARCHETTI, A
    JOURNAL OF HEPATOLOGY, 1987, 5 : S97 - S97
  • [26] Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients
    Varghese J.
    Reddy M.S.
    Cherian T.
    Vijaya S.
    Jayanthi V.
    Rela M.
    Indian Journal of Gastroenterology, 2014, 33 (3) : 226 - 230
  • [27] Ambulatory long-term immunoprophylaxis with intramuscular anti-HBS immunoglobulin to prevent hepatitis B reinfection after orthotopic liver transplantation.
    Faust, D
    Rabenau, H
    Caspary, WF
    Zeuzem, S
    GASTROENTEROLOGY, 2000, 118 (04) : A996 - A996
  • [28] Residual HBV DNA at 10 years post-transplantation in patients receiving long-term anti-HBS immunoglobulins (HBIG).
    Gigou, M
    Feray, C
    Roche, B
    Roque-Al-fonso, AM
    Shouval, D
    Dussaix, E
    Petit, MA
    Bismuth, H
    Samuel, D
    HEPATOLOGY, 2000, 32 (04) : 218A - 218A
  • [29] High-titered anti-HBs fresh frozen plasma for immunoprophylaxis against hepatitis B virus recurrence after liver transplantation
    Mentha, G
    Giostra, E
    Negro, F
    RubbiaBrandt, L
    Huber, O
    Hadengue, A
    Perrin, L
    Morel, P
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (05) : 2369 - 2373
  • [30] Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation
    Sousa, JM
    Pareja, F
    Serrano, J
    Gómez, MA
    García, I
    Tamayo, MJ
    Díaz, C
    Martín, C
    Pascasio, JM
    Hinojosa, R
    Pérez-Bernal, JB
    Cañas, E
    Sayago, M
    Bernardos, A
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 723 - 724